The Cancer Biology Training Program (the Program) at The University of Michigan, currently in its twentieth year, is an interdisciplinary program whose central goal is to train exceptional junior investigators to address fundamental biological problems related to human cancer. The Program draws its strength from: the participation of 40 faculty members from 14 basic science and clinical departments within The University of Michigan;its association with The University of Michigan Comprehensive Cancer Center;and its involvement with the Program in Biomedical Sciences, through which graduate students are recruited to the Program. The Program trains both predoctoral and postdoctoral scholars with research opportunities focusing on a wide choice of topics in the field of cancer biology. In addition, it provides these trainees with didactic coursework and other programmatic activities that expose them to the depth and breadth of cancer research. Postdoctoral fellows will have completed a Ph.D. degree in one of the physical or biological sciences, or have completed an M.D. degree. Predoctoral students will comprise a subset of students accepted into the recently-approved Doctoral Program in Cancer Biology. All trainees have a significant interest in pursuing a career in some aspect of cancer-related research. Predoctoral trainees will be expected to graduate to outstanding postdoctoral positions, while postdoctoral trainees should assume leading academic and research positions.
Cancer is one of the leading causes of illness and death in the United States. Determining the causes of cancer and discovery of new therapeutic approaches is required to improve the outcomes of cancer patients. The purpose of this grant is to train the next generation of cancer researchers, allowing them to make strides in the future as we continue to battle this disease.
| Rosselli-Murai, Luciana K; Yates, Joel A; Yoshida, Sei et al. (2018) Loss of PTEN promotes formation of signaling-capable clathrin-coated pits. J Cell Sci 131: |
| Pinatti, L M; Walline, H M; Carey, T E (2018) Human Papillomavirus Genome Integration and Head and Neck Cancer. J Dent Res 97:691-700 |
| Halbrook, Christopher J; Pasca di Magliano, Marina; Lyssiotis, Costas A (2018) Tumor cross-talk networks promote growth and support immune evasion in pancreatic cancer. Am J Physiol Gastrointest Liver Physiol 315:G27-G35 |
| Schofield, Heather K; Zeller, Jörg; Espinoza, Carlos et al. (2018) Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma. JCI Insight 3: |
| Wang, Qing; Yan, Ran; Pinnell, Nancy et al. (2018) Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development. Blood 132:1279-1292 |
| McDermott, Sarah C; Rodriguez-Ramirez, Christie; McDermott, Sean P et al. (2018) FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin. Oncotarget 9:25148-25165 |
| Hartlerode, Andrea J; Regal, Joshua A; Ferguson, David O (2018) Reversible mislocalization of a disease-associated MRE11 splice variant product. Sci Rep 8:10121 |
| Sanchez-Vega, Francisco; Mina, Marco; Armenia, Joshua et al. (2018) Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell 173:321-337.e10 |
| Schofield, Heather K; Tandon, Manuj; Park, Min-Jung et al. (2018) Pancreatic HIF2? Stabilization Leads to Chronic Pancreatitis and Predisposes to Mucinous Cystic Neoplasm. Cell Mol Gastroenterol Hepatol 5:169-185.e2 |
| Hawkins, Allegra G; Basrur, Venkatesha; da Veiga Leprevost, Felipe et al. (2018) The Ewing Sarcoma Secretome and Its Response to Activation of Wnt/beta-catenin Signaling. Mol Cell Proteomics 17:901-912 |
Showing the most recent 10 out of 185 publications
